The 20 Best Neuroendocrine Carcinoma of the Cervix Doctors Near Me in Ann Arbor, MI

Dr. Hansen is a graduate of the University of Michigan. She then completed her medical degree at the Kirksville College of Osteopathic Medicine and residency training at the University of Iowa Hospitals and Clinics. She completed her gynecologic oncology fellowship at MD Anderson Cancer Center. She joined the faculty as an assistant professor in 2018. She serves on national committees for both the Society of Gynecologic Oncology and NRG Oncology. She is the principal investigator for Gynecologic Oncology Group (GOG) and industry-sponsored clinical research trials available at the University of Michigan. Dr. Siedel is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Malignant Mixed Mullerian Tumor, and Testicular Yolk Sac Tumor.

Dr. Uppal is a board-certified Gynecologic Oncologist and Division Chief for the Gynecology Oncology service at the University of Michigan. He is also the Director of Gynecologic Oncology Initiatives at the Michigan Oncology Quality Consortium (MOQC) - a statewide quality improvement network. Dr. Uppal received his medical degree from the All India Institute of Medical Sciences (AIIMS) in New Delhi, India. He completed his Obstetrics and Gynecology residency at Temple University Hospital in Philadelphia and a fellowship in Gynecology Oncology at the University of Wisconsin in Madison, Wisconsin. He joined the faculty of the University of Michigan in 2014. Dr. Uppal also holds a Master in Business Administration (MBA) from the University of the Michigan Stephen M. Ross School of Business.Dr. Uppal has been in clinical practice for over ten years and is involved in many Quality Improvement Projects in the Division of Gynecologic Oncology, nationally and across Michigan. Widely acknowledged as a thought leader in Gynecology Oncology and quality-of-care, he has authored over 75 peer-reviewed manuscripts and instituted changes in the health system to improve outcomes after surgery, reduce the cost of care and implemented patient-centered care delivery systems. Dr. Uppal is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Oophorectomy. Dr. Uppal is board certified in Gynecologic Oncology and Obstetrics & Gynecology.

Melissa Brackmann, MD is an Assistant Professor of Gynecologic Oncology at the University of Michigan Medical School.Dr. Brackmann graduated from the University of Michigan with a degree in Cellular and Molecular Biology. She received her medical degree from Harvard Medical School in 2013 and completed residency in OBGYN at Michigan Medicine in 2017, followed by fellowship in Gynecologic Oncology at Michigan Medicine in 2020. She was faculty at the University of Utah from 2020 to 2023, where she served as the Associate Residency Program Director for the OBGYN residency program and Director of the Core Sub-Internship in Gynecologic Oncology. She returned to Michigan Medicine as an Assistant Professor in 2023.Dr. Brackmann's clinical interests include the surgical and medical management of gynecologic cancers, placenta accreta spectrum, minimally invasive surgical techniques and patient/family education.Dr. Brackmann's research interests include post-graduate medical education, surgical simulation and quality improvement.Outside of medicine, Dr. Brackmann enjoys spending time with friends and family and watching college football. Dr. Brackmann is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Malignant Mixed Mullerian Tumor, and Testicular Yolk Sac Tumor. Dr. Brackmann is board certified in Obstetrics & Gynecology and Gynecologic Oncology.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

Stefany Acosta is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Ann Arbor, Michigan. Dr. Acosta is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Cervical Cancer, and Splenectomy. Dr. Acosta is board certified in Obstetrics & Gynecology and Gynecologic Oncology.

Medical school: Creighton University School of Medicine; Internship: University of Michigan Hospitals- Pediatrics/Internal Medicine; Residency: University of Cleveland Hospitals- Radiation Oncology. Dr. Kane is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Breast Cancer. Dr. Kane is board certified in Radiation Oncology.

Dr. Lieberman is a Clinical Professor of Obstetrics & Gynecology and Pathology. Dr. Lieberman received a BA from Wittenberg University in Springfield, Ohio and an M.D. from The Uniform Services, University of Health Sciences in Bethesda, Maryland. He completed an internship and residency training in Obstetrics and Gynecology at the United States Air Force Medical Center, Keesler Airforce Base (Mississippi). Following an overseas tour of duty with the USAF, in 1990 he initiated residency training in Anatomic Pathology at the National Naval Medical Center in Bethesda, Maryland and subsequently completed a Fellowship in Gynecologic Pathology at the Armed Forces Institute of Pathology in Washington, D.C.Dr. Lieberman served as a physician with the U.S. Air Force, Medical Corps from 1979-1996. During this period he served as Chief of Obstetrics & Gynecology at RAF Upper Heyford in the United Kingdom, was appointed Adjunct Clinical Instructor of Pathology and Assistant Professor of Pathology at the Uniformed Services of Health Sciences in Bethesda. Upon retirement from the U.S. Air Force, Dr. Lieberman joined the faculty at the University of Michigan Medical School as Clinical Assistant Professor in the Departments of Pathology and Obstetrics and Gynecology in 1997.Dr. Lieberman is board certified in Obstetrics and Gynecology and Anatomic Pathology. Dr. Lieberman is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Cervical Dysplasia, Human Papillomavirus Infection, Vaginal Cancer, and Bowenoid Papulosis. Dr. Lieberman is board certified in Pathology-Anatomic, Obstetrics & Gynecology, and Anatomic & Clinical Pathology.

R Reynolds is an Obstetrics and Gynecologist practicing medicine in Ann Arbor, Michigan. Dr. Reynolds is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Endometrial Cancer, Hysterectomy, and Hernia Surgery.

Zhen Zhou is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Ann Arbor, Michigan. Dr. Zhou is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Testicular Yolk Sac Tumor, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Hysterectomy, and Intrauterine Device Insertion. Dr. Zhou is board certified in Gynecologic Oncology and Obstetrics & Gynecology.

Kirk Frey is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Frey is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Neuroendocrine Tumor, Osteopenia, and Hormone Replacement Therapy (HRT).

Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer. Dr. Chang is board certified in Radiation Oncology.

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Marie-adele Kress is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. She has been practicing medicine for over 17 years. Dr. Kress is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Laryngeal Cancer, Prostate Cancer, and Pleuropulmonary Blastoma.

James Fugazzi is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Fugazzi is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Fugazzi is board certified in Radiation Oncology.

Karen Mclean is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mclean is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Endometrial Cancer, Hernia Surgery, and Bladder Reconstruction.

Eva Bieniek is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Bieniek is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Endometrial Cancer.

Samir Narayan is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Narayan is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Posterior Fossa Tumor.

Joel Wilkie is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Wilkie is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses HER-2 Positive Breast Cancer, Lung Cancer, Prostate Cancer, and Familial Prostate Cancer.

Walter Sahijdak is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Sahijdak is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Bryan Squires is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Squires is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. His clinical expertise encompasses HER-2 Positive Breast Cancer, Lung Cancer, Metastatic Brain Tumor, and Prostate Cancer.